Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Chen, Hongyan ^a   Miao, Qing ^b   Geng, Miao ^a   Liu, Jing ^a   Hu, Yazhuo ^a   Tian, Lei ^a   Pan, Jingkun ^a   Yang, Yi ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c MINZU UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; PROTEIN BAX; PROTEIN BCL 2; RUTOSIDE; TUMOR NECROSIS FACTOR ALPHA; BAX PROTEIN, HUMAN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; NEUROBLASTOMA; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RUTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896346155     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/269165     Document Type: Article

References (24)

1. Maris J. M., Recent advances in neuroblastoma. The New England Journal of Medicine 2010 362 23 2154 2211 2-s2.0-77953523121
2. Mueller S., Matthay K. K., Neuroblastoma: biology and staging. Current Oncology Reports 2009 11 6 431 438 2-s2.0-70350144841 10.1007/s11912-009-0059-6
3. Jia L., Ma S., Hou X., Wang X., Qased A. B., Sun X., Liang N., Li H., Yi H., Kong D., Liu X., Fan F., The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment. Oncology Letters 2013 5 5 1439 1447
4. Nile S. H., Park S. W., Edible berries: review on bioactive components and their effect on human health. Nutrition 2013 10.1016/j.nut.2013.04.007
5. Hoensch H., Oertel R., Anti-inflammatory effects of tea-flavonoids. Deutsche Medizinische Wochenschrift 2012 137 51-52 2738 2740
6. Geybels M. S., Verhage B. A., Arts I. C., van Schooten F. J., Goldbohm R. A., van den Brandt P. A., Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. American Journal of Epidemiology 2013 177 12 1388 1398
7. Evans K., Flavonoids in fruits, vegetables and nuts dramatically lower cancer rates. Tags: cancer, flavonoids, health news, September 2011
8. Chan H. J., Ji Y. L., Chul H. C., Chang J. K., Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Archives of Pharmacal Research 2007 30 12 1599 1607 2-s2.0-38049184767
9. Volate S. R., Davenport D. M., Muga S. J., Wargovich M. J., Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 2005 26 8 1450 1456 2-s2.0-24944522546 10.1093/carcin/bgi089 (Pubitemid 41417889)
10. Yue G., Wei J., Qian X., Yu L., Zou Z., Guan W., Wang H., Shen J., Liu B., Synergistic anticancer effects of polyphyllin and evodiamine on freshly-removed human gastric tumors. PLoS ONE 2013 8 6 10.1371/journal.pone. 0065164 e65164
11. Yan X., Lyu T., Jia N., Yu Y., Hua K., Feng W., Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3 β / β -catenin pathway. PLoS ONE 2013 8 5 10.1371/journal.pone.0063731 e63731
12. Hunyadi A., Martins A., Hsieh T. J., Seres A., Zupkó I., Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS ONE 2012 7 11 10.1371/journal.pone.0050619 e50619
13. Sharma S., Ali A., Ali J., Sahni J. K., Baboota S., Rutin: therapeutic potential and recent advances in drug delivery. Expert Opinion on Investigational Drugs 2013 22 8 1063 1079
14. Majewska-Wierzbicka M., Czeczot H., Anticancer activity of flavonoids. Polski Merkuriusz Lekarski 2012 33 198 364 369
15. Zhao Y., Jiang W., Li B., Yao Q., Dong J., Cen Y., Pan X., Li J., Zheng J., Pang X., Zhou H., Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase. International Immunopharmacology 2011 11 12 2039 2046 2-s2.0-81855168327 10.1016/j.intimp.2011.08.017
16. Zhang M., Zhang P., Zhang C., Sun J., Wang L., Li J., Tian Z., Chen W., Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2009 38 3 307 313 2-s2.0-61349141974 10.1111/j.1600-0714.2008.00689.x
17. Faggiano A., Sabourin J.-C., Ducreux M., Lumbroso J., Duvillard P., Leboulleux S., Dromain C., Colao A., Schlumberger M., Baudin E., Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features. Cancer 2007 110 2 265 274 2-s2.0-34547168084 10.1002/cncr.22791 (Pubitemid 47121885)
18. Kulbe H., Thompson R., Wilson J. L., Robinson S., Hagemann T., Fatah R., Gould D., Ayhan A., Balkwill F., The inflammatory cytokine tumor necrosis factor- α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Research 2007 67 2 585 592 2-s2.0-33846682591 10.1158/0008-5472.CAN-06-2941 (Pubitemid 46192196)
19. Eilers M., Eisenman R. N., Myc's broad reach. Genes and Development 2008 22 20 2755 2766 2-s2.0-54349087788 10.1101/gad.1712408
20. Meyer N., Penn L. Z., Reflecting on 25 years with MYC. Nature Reviews Cancer 2008 8 12 976 990 2-s2.0-56749184298 10.1038/nrc2231
21. Vita M., Henriksson M., The Myc oncoprotein as a therapeutic target for human cancer. Seminars in Cancer Biology 2006 16 4 318 330 2-s2.0-33748192942 10.1016/j.semcancer.2006.07.015 (Pubitemid 44311040)
22. Huang M., Weiss W. A., Neuroblastoma and MYCN. Cold Spring Harbor Perspectives in Medicine 2013 3 10 014415
23. Edsjö A., Holmquist L., Påhlman S., Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Seminars in Cancer Biology 2007 17 3 248 256 2-s2.0-33947138135 10.1016/j.semcancer.2006.04.005 (Pubitemid 46413077)
24. Westermark U. K., Wilhelm M., Frenzel A., Henriksson M. A., The MYCN oncogene and differentiation in neuroblastoma. Seminars in Cancer Biology 2011 21 4 256 266 2-s2.0-80655127696 10.1016/j.semcancer.2011.08.001